DUX4 and acute lymphoblastic leukemia: Flow cytometry may be used to detect CRLF2 rearrangements, that result in cell surface expression of CRLF2, as well as markers associated with distinct subtypes (e.g., CD371 in DUX4-rearranged ALL).